tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

PHAR

1

Getting the most from clinical experts in the time of COVID-19: Lessons learned

Posted on April 5, 2021 by Michael Broder

Gathering experts and soliciting their advice is a time-honored tactic. But methods for doing so invariably involve meeting in person. Although the threat of COVID-19 appears to be slowly receding, business travel may take years to return to pre-crisis levels.… Continue Reading →

COVID-19, PHAR covid-19, PHAR
0

The 5 Numbers That Will Define Healthcare Value in 2021

Posted on January 11, 2021 by Michael Broder

19. As in COVID. Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. Continue Reading →

Guest Bloggers, PHAR ACA, affordable care act, coronavirus, covid-19, health care value, ICER, Michael Broder, PHAR, vaccines
0

How Health Economics and Outcomes Researchers Can Help Defeat COVID-19

Posted on October 6, 2020 by Michael Broder

As of October 2, 2020, the novel coronavirus has infected more than 34 million people, including President Donald J. Trump and First Lady Melania Trump, and killed over one million, resulting in a global economic decline on a scale not… Continue Reading →

COVID-19, Guest Bloggers, PHAR coronavirus, covid-19, Michael Broder, PHAR

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • How Accelerated Drug Development Requires Disruption in Market Access and Pricing
  • The UK market access has always been complex, now even more than before, Graham Foxon and Paul Craddy?
  • How to Change Clinical Practice Using Health Economics and Outcomes Research
  • Switzerland is strong in many aspects, so also in its health care system, Dr. Peter Indra?

HealthEconomics.Com Twitter Feed

HealthEconomics.Com | A Scientist.com Company Follow

www_healthecon
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
1h

New App from French Biotech Personalizes Drug Side Effects

http://ow.ly/IKPz50KooCP

#HEOR #Healthcare #Pharma #Therapeutics #DigitalHealth

Reply on Twitter 1560752797502607360 Retweet on Twitter 1560752797502607360 1 Like on Twitter 1560752797502607360 Twitter 1560752797502607360
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
2h

Cytel Webinar: US Drug Pricing Reform: Potential impact on Pharma HEOR Evidence Generation - September 8th

http://ow.ly/KAPc50KomRI

#HEOR #DrugPricing #Medicare #Pharma #ValueAssessment

Reply on Twitter 1560737131177410561 Retweet on Twitter 1560737131177410561 Like on Twitter 1560737131177410561 Twitter 1560737131177410561
www_healthecon HealthEconomics.Com | A Scientist.com Company @www_healthecon ·
3h

Regulatory Filing Shows Bidding War Between Major Retailers Over One Medical

http://ow.ly/BGwj50Kojbs

#HEOR #MandAs #Healthcare #Pharma

Reply on Twitter 1560719610994987008 Retweet on Twitter 1560719610994987008 Like on Twitter 1560719610994987008 Twitter 1560719610994987008
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2022 tHEORetically Speaking. All rights reserved.
Hiero by aThemes